Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance.
about
KASL clinical practice guidelines: management of chronic hepatitis BNested case-control study: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance.Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions.Artificial neural network accurately predicts hepatitis B surface antigen seroclearance.Hepatitis B virus-induced oncogenesis.Comparison of serum HBsAg quantitation by four immunoassays, and relationships of HBsAg level with HBV replication and HBV genotypes.Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samplesKASL Clinical Practice Guidelines: Management of chronic hepatitis B.Low serum hyaluronic acid levels associated with spontaneous HBsAg clearance.Tumor stroma with senescence-associated secretory phenotype in steatohepatitic hepatocellular carcinoma.The Hepatitis Viral Status in Patients With Hepatocellular Carcinoma: a Study of 3843 Patients From Taiwan Liver Cancer NetworkMolecular testing in the diagnosis and management of chronic hepatitis BOptimal Follow-up of Patients with Viral Hepatitis Improves the Detection of Early-stage Hepatocellular Carcinoma and the Prognosis of Survival.Prevalence and molecular analysis of occult hepatitis B virus infection isolated in a sample of cryptogenic cirrhosis patients in iran.Pathogenesis of occult chronic hepatitis B virus infectionPrevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.Natural history of chronic hepatitis B: what exactly has REVEAL revealed?When to stop nucleos(t)ide analogues treatment for chronic hepatitis B? Durability of antiviral response.Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective study.Emerging drugs for the treatment of hepatitis B.Systematic review with meta-analysis: development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis B surface antigen seroclearance.Hepatitis B virus regulates Raf1 expression in HepG2.2.15 cells by enhancing its promoter activity.Clinical characteristics and potential aetiologies of non-B non-C hepatocellular carcinoma in hepatitis B virus endemic area.Analysis of HBsAg using high-sensitivity HBsAg assays in hepatitis B virus carriers in whom HBsAg seroclearance was confirmed by conventional assays.Differential expression of innate immune response genes in clinical phases of chronic hepatitis B infection.Clinical outcomes after spontaneous and nucleos(t)ide analogue-treated HBsAg seroclearance in chronic HBV infection.Serum interferon-inducible protein 10 levels predict hepatitis B s antigen seroclearance in patients with chronic hepatitis B.Prevalence of HBV and HCV among outpatients in the Plovdiv region of Bulgaria, 2010-2011.Serological and clinical outcomes of horizontally transmitted chronic hepatitis B infection in New Zealand Māori: results from a 28-year follow-up study.Loss of HBsAg and antiviral treatment: from basics to clinical significance.JSH Guidelines for the Management of Hepatitis B Virus Infection.Long-term outcome in Caucasian patients with chronic hepatitis B virus infection after HBsAg seroclearance.Occult hepatitis B: clinical viewpoint and management.A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance.Clinical and virological characteristics post HBsAg seroclearance in hepatitis B virus carriers with hepatic steatosis versus those without.Elimination of hepatitis B virus surface antigen and appearance of neutralizing antibodies in chronically infected patients without viral clearance.Letter: older age and male gender increase the risk of hepatocellular carcinoma after hepatitis B surface antigen (HBsAg) seroclearance.Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance.Seroclearance rate of hepatitis B surface antigen in 2,112 patients with chronic hepatitis in Japan during long-term follow-up.Hepatic flares promote rapid decline of serum hepatitis B surface antigen (HBsAg) in patients with HBsAg seroclearance: A long-term follow-up study.
P2860
Q26752475-FBFEDA02-C834-4C0E-B177-DFA43D8113ECQ30152115-5F1B9D3D-0A37-4AD7-9697-5B79AA6CA402Q33718958-F485099D-4816-4149-98AC-5F9D0FA35246Q33734215-AAD9DC89-046C-4338-9458-33162191FAADQ33787553-89D11B39-AE15-4715-A73B-7679D5C6F384Q34189348-82940CC0-40A3-452F-B1D3-8118FF1020E5Q35117388-D382975A-7BF1-4032-B9B5-3BB39B7AF513Q36153966-60A70CBF-57C3-4763-9F96-17F8C0A23BE4Q36167463-D038622D-6199-490E-B650-B923FD1DA677Q36300899-EB4B6B90-42BB-4A70-9290-28CE1E81A99FQ36822340-3CC0F21D-9CC5-4C20-B4B6-B6BB8CE9141DQ36881140-DA9349A8-85DB-45C7-8D3F-E60943F0A8D9Q37383131-78C89FAF-FE2C-48AE-B0FE-B15C45A4E639Q37686496-03FEFC68-C217-4286-87F0-25183EE3ACBDQ37862591-C5B1EEB1-2CBC-4110-A9BE-04FC33C16C2CQ37972806-69D3A42A-A6D7-4813-84C0-FEC0F301330EQ38003214-83311D72-4A79-48FD-BC13-4884AE689300Q38223364-842DFEFA-CB8A-4D84-A8F8-4A22BFB1AA9FQ38383062-66F9A769-E7A0-47B1-9F20-57F0EADABBABQ38759805-AF02E2D9-6481-45E9-8DEB-CA6D4F1CB67EQ38818469-59C0D80A-54FE-42E5-ABF8-1410DEA43DE9Q39612071-C71AF25D-DCD2-461E-BB6A-344FE77F4495Q39970001-74EB19ED-E5EA-4CF2-AB9D-A85EEED70E7BQ40051443-138C3087-0808-4ABF-856F-C562715B5121Q40325365-E04BFD68-4062-4C7B-93CF-333BA0127576Q40717249-F4CAE0B0-131B-47A7-BC95-947C2ABE3EE5Q41157144-C8E40B3B-3E39-4EE5-8D47-F92445689CEBQ42197268-3823ED0F-9452-47A9-B802-F2FCA0FDCEE8Q42206945-EB19E131-433C-4096-9EAB-671EB4389A07Q42235230-77A1D027-63DD-49CF-8299-FD09EF9C1A75Q42244740-32DDEB2A-D247-4D99-B939-0FCEC397700FQ42245019-9E2CADF7-9D4F-4D8B-BB15-7BF3D5234336Q43223881-1B8D720D-1B80-49CE-8A59-02076CE93943Q44766209-9B07496E-DE7D-41F7-9F76-891C0E6D8158Q44983054-220B022B-F4A1-4E68-8200-9367BCFF6A69Q45373267-D67F6914-E12F-4976-9FDC-07E012667133Q47615545-AD0C57C1-FB90-4462-874F-A1B3AE6A5C17Q50190669-A4186009-64BB-4EB5-A784-F1957DFA72EBQ51217648-5B9290E0-CA81-4D5A-AD0F-D92DCFEABDADQ51279529-62F68E33-1785-46C6-AA7E-12D2B2013D89
P2860
Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Long-term clinical and histolo ...... surface antigen seroclearance.
@en
type
label
Long-term clinical and histolo ...... surface antigen seroclearance.
@en
prefLabel
Long-term clinical and histolo ...... surface antigen seroclearance.
@en
P2093
P1476
Long-term clinical and histolo ...... surface antigen seroclearance
@en
P2093
Chae Yoon Chon
Chanil Park
Hye-Young Chang
Ji Eun Shin
Jun Yong Park
Jung Min Lee
Young Myoung Moon
Young Nyun Park
P304
P356
10.1016/J.JHEP.2004.10.026
P577
2005-02-01T00:00:00Z